FindTrial
Sign In

Clinical evaluation of the Zilico ZedScan I as an adjunct in women referred to colposcopy

Clinical evaluation of the Zilico ZedScan I as an adjunct for the detection of CIN in women referred to colposcopy with abnormal cytology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/04/008303
Enrollment
300
Registered
2017-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients referred for colposcopy due to abnormal pap smear / clinical findings Screening for Cervical cancer / precancerous conditions

Interventions

Intervention1: Zed Scan: Zilico Zed scan which works on the principle of Electrical impedance Spectrography will be used in adjunct with a colposcope to detect cervical cancer / precancerous lesions

Sponsors

Zilico
Lead Sponsor
International oncology Services Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult females referred for colposcopy with abnormal cervical smear or relevant clinical findings consenting to undergo EIS.

Exclusion criteria

Exclusion criteria: Pregnant & actively menstruating women

Design outcomes

Primary

MeasureTime frame
Cases of Cervical cancer / precancerous cases detected. Timepoint: 6 months—

Secondary

MeasureTime frame
Reduction in patient biopsy (if applicable), PPV for the disease, provider & patient satisfaction.Timepoint: 6 months—

Countries

India

Contacts

Public ContactMr Vibhav Gupta

International Oncology Services Pvt Ltd

dior.kara@iosplcancer.com9920099156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026